Literature DB >> 9040805

Pituitary adenoma and bilateral male breast cancer: an unusual association.

M D Volm1, M S Talamonti, M Thangavelu, W K Gradishar.   

Abstract

An unusual case is presented of bilateral breast cancer in a male patient with a long history of endocrine dysfunction due to a prolactinoma. The role of abnormal endocrine function in the development of male breast cancer is reviewed. The strongest association between aberrant endocrine function and male breast cancer occurs in patients with Klinefelter's syndrome, who have an approximate 3% lifetime risk of developing breast cancer. Retrospective case-control studies indicate that both estrogen excess and androgen deficiency may be involved in male breast cancer. Clinical studies of estrogen, androgen, and prolactin levels in male breast cancer patients have yielded conflicting results, and the precise nature of the hormonal mechanisms involved in the development of male breast cancer remains to be defined.

Entities:  

Mesh:

Year:  1997        PMID: 9040805     DOI: 10.1002/(sici)1096-9098(199701)64:1<74::aid-jso14>3.0.co;2-w

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  11 in total

1.  Pituitary prolactin-secreting macroadenoma combined with bilateral breast cancer in a 45-year-old male.

Authors:  F Forloni; M Giovilli; C Pecis; E Bortolani; A Preziosi; M E Barzaghi; D Corti; P Beck-Peccoz
Journal:  J Endocrinol Invest       Date:  2001-06       Impact factor: 4.256

Review 2.  A rare case of male breast ductal carcinoma in-situ associated with prolactinoma.

Authors:  Chandike Maithri Mallawaarachchi; Snezana Ivanova; Alice Shorthouse; Sami Shousha; Dudley Sinnett
Journal:  BMJ Case Rep       Date:  2011-08-31

3.  Synchronous bilateral breast carcinoma in a 50-year-old man with 45,X/46,XY mosaic karyotype: report of a case.

Authors:  Gianluca Franceschini; Pierfrancesco D'Alba; Melania Costantini; Andrea Magistrelli; Paolo Belli; Antonino Mulè; Claudio Coco; Aurelio Picciocchi
Journal:  Surg Today       Date:  2006       Impact factor: 2.549

4.  Arc and resistance welding and tumours of the endocrine glands: a Swedish case-control study with focus on extremely low frequency magnetic fields.

Authors:  N Håkansson; C Stenlund; P Gustavsson; C Johansen; B Floderus
Journal:  Occup Environ Med       Date:  2005-05       Impact factor: 4.402

Review 5.  The role of prolactin in mammary carcinoma.

Authors:  Charles V Clevenger; Priscilla A Furth; Susan E Hankinson; Linda A Schuler
Journal:  Endocr Rev       Date:  2003-02       Impact factor: 19.871

6.  Synchronous bilateral breast cancer in a male patient following hormone therapy for prostate cancer.

Authors:  Yuko Kijima; Heiji Yoshinaka; Munetsugu Hirata; Yoshihisa Umekita; Sumika Matsukita; Takashi Arima; Masayuki Nakagawa; Hizuru Kumemura; Nobuo Hamada; Koichi Kaneko; Yawara Funasako; Shoji Natsugoe
Journal:  Int J Clin Oncol       Date:  2009-07-11       Impact factor: 3.402

Review 7.  Second cancers in patients with male breast cancer: a literature review.

Authors:  Tal Grenader; Anthony Goldberg; Linda Shavit
Journal:  J Cancer Surviv       Date:  2008-04-01       Impact factor: 4.442

Review 8.  Prolactin and breast cancer etiology: an epidemiologic perspective.

Authors:  Shelley S Tworoger; Susan E Hankinson
Journal:  J Mammary Gland Biol Neoplasia       Date:  2008-02-02       Impact factor: 2.673

9.  Male breast cancer: a review.

Authors:  Is Fentiman
Journal:  Ecancermedicalscience       Date:  2009-03-20

10.  The risk for breast cancer is not evidently increased in women with hyperprolactinemia.

Authors:  O M Dekkers; J A Romijn; A de Boer; J P Vandenbroucke
Journal:  Pituitary       Date:  2010-09       Impact factor: 4.107

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.